Quick Takeaways
- Era Regenerative Medicine Ltd filed SCHEDULE 13D/A for Reed's, Inc. Common Stock (REED).
- Disclosed ownership: 58%.
- Date of event: 04 Jun 2025.
Era Regenerative Medicine Ltd - 04 Jun 2025 SCHEDULE 13D/A Report for Reed's, Inc. Common Stock (REED)
- Filing Manager
- Era Regenerative Medicine Ltd
- Reporting Manager
- Era Regenerative Medicine Ltd
- Security
- Reed's, Inc. Common Stock
- Symbol
- REED
- Shares outstanding
- 48,814,514 shares
- Disclosed Ownership
- 28,214,789 shares
- Ownership
- 58%
- Form type
- SCHEDULE 13D/A
- Filing time
- 11 Jun 2025, 16:47:25 UTC
- Date of event
- 04 Jun 2025
- Previous filing
- 02 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Era Regenerative Medicine Ltd disclosed 58% ownership in Reed's, Inc. Common Stock (REED) on 04 Jun 2025."
What Changed
- Previous schedule filing date: 02 May 2025.
- Current filing was accepted on 11 Jun 2025, 16:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Era Regenerative Medicine Ltd | 58% | 28,214,789 | 0 | 28,214,789 | /s/ Dai Siqi | Dai Siqi, Director | 0002053961 |
| D&D Source of Life Holding Ltd. | 58% | 28,214,789 | 0 | 28,214,789 | /s/ Dai Siqi | Dai Siqi, on behalf of Era Regenerative Medicine Ltd as its Director | 0001979652 |